Citius Oncology, Inc. (CTOR)
NASDAQ: CTOR · Real-Time Price · USD
1.730
-0.020 (-1.14%)
Oct 30, 2025, 4:00 PM EDT - Market closed
Citius Oncology Market Cap
Citius Oncology has a market cap or net worth of $144.48 million as of October 30, 2025. Its market cap has increased by 92.97% in one year.
Market Cap
144.48M
Enterprise Value
148.28M
1-Year Change
92.97%
Ranking
Category
Stock Price
$1.73
Market Cap Chart
Since December 8, 2022, Citius Oncology's market cap has increased from $90.21M to $144.48M, an increase of 60.15%. That is a compound annual growth rate of 17.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 29, 2025 | 146.15M | 77.61% |
| Dec 31, 2024 | 82.29M | -15.88% |
| Dec 29, 2023 | 97.81M | 7.68% |
| Dec 30, 2022 | 90.84M | 0.69% |
| Dec 8, 2022 | 90.21M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 738.55B |
| Johnson & Johnson | 450.00B |
| AbbVie | 402.76B |
| UnitedHealth Group | 337.35B |
| AstraZeneca | 259.35B |
| Novartis AG | 250.89B |
| Novo Nordisk | 235.38B |
| Abbott Laboratories | 221.40B |